BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

355 related articles for article (PubMed ID: 32276211)

  • 1. Anti-microbial and anti-biofilm activities of combined chelerythrine-sanguinarine and mode of action against Candida albicans and Cryptococcus neoformans in vitro.
    Qian W; Yang M; Li X; Sun Z; Li Y; Wang X; Wang T
    Colloids Surf B Biointerfaces; 2020 Jul; 191():111003. PubMed ID: 32276211
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vitro antifungal and antibiofilm activities of halogenated quinoline analogues against Candida albicans and Cryptococcus neoformans.
    Zuo R; Garrison AT; Basak A; Zhang P; Huigens RW; Ding Y
    Int J Antimicrob Agents; 2016 Aug; 48(2):208-11. PubMed ID: 27256584
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antifungal and Antibiofilm Efficacy of Paeonol Treatment Against Biofilms Comprising
    Qian W; Li X; Liu Q; Lu J; Wang T; Zhang Q
    Front Cell Infect Microbiol; 2022; 12():884793. PubMed ID: 35669114
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Activity of Sanguinarine against Candida albicans Biofilms.
    Zhong H; Hu DD; Hu GH; Su J; Bi S; Zhang ZE; Wang Z; Zhang RL; Xu Z; Jiang YY; Wang Y
    Antimicrob Agents Chemother; 2017 May; 61(5):. PubMed ID: 28223387
    [No Abstract]   [Full Text] [Related]  

  • 5. Chelerythrine reverses the drug resistance of resistant
    Gong Y; Yin S; Sun S; Li M
    Future Microbiol; 2022 Nov; 17():1325-1333. PubMed ID: 36111728
    [No Abstract]   [Full Text] [Related]  

  • 6.
    Gong Y; Li S; Wang W; Li Y; Ma W; Sun S
    Future Microbiol; 2019 Dec; 14():1545-1557. PubMed ID: 31992072
    [No Abstract]   [Full Text] [Related]  

  • 7. Thymus vulgaris essential oil and thymol inhibit biofilms and interact synergistically with antifungal drugs against drug resistant strains of Candida albicans and Candida tropicalis.
    Jafri H; Ahmad I
    J Mycol Med; 2020 Apr; 30(1):100911. PubMed ID: 32008964
    [TBL] [Abstract][Full Text] [Related]  

  • 8.
    Tetz G; Collins M; Vikina D; Tetz V
    Antimicrob Agents Chemother; 2019 Apr; 63(4):. PubMed ID: 30917977
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of Antifungal Efficacy of Three New Cyclic Lipopeptides of the Class Bacillomycin from Bacillus subtilis RLID 12.1.
    Ramachandran R; Shrivastava M; Narayanan NN; Thakur RL; Chakrabarti A; Roy U
    Antimicrob Agents Chemother; 2018 Jan; 62(1):. PubMed ID: 29038271
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Alexidine Dihydrochloride Has Broad-Spectrum Activities against Diverse Fungal Pathogens.
    Mamouei Z; Alqarihi A; Singh S; Xu S; Mansour MK; Ibrahim AS; Uppuluri P
    mSphere; 2018 Oct; 3(5):. PubMed ID: 30381356
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vitro determination of optimal antifungal combinations against Cryptococcus neoformans and Candida albicans.
    Ghannoum MA; Fu Y; Ibrahim AS; Mortara LA; Shafiq MC; Edwards JE; Criddle RS
    Antimicrob Agents Chemother; 1995 Nov; 39(11):2459-65. PubMed ID: 8585726
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vitro antifungal activity of eugenol and vanillin against Candida albicans and Cryptococcus neoformans.
    Boonchird C; Flegel TW
    Can J Microbiol; 1982 Nov; 28(11):1235-41. PubMed ID: 6758923
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antifungal activity of promethazine and chlorpromazine against planktonic cells and biofilms of Cryptococcus neoformans/Cryptococcus gattii complex species.
    Brilhante RSN; Gotay WJP; Pereira VS; de Oliveira JS; Pereira-Neto WA; Castelo-Branco DSCM; Cordeiro RA; Sidrim JJC; Rocha MFG
    Med Mycol; 2020 Oct; 58(7):906-912. PubMed ID: 32016364
    [TBL] [Abstract][Full Text] [Related]  

  • 14.
    Fu Y; Liu W; Liu M; Zhang J; Yang M; Wang T; Qian W
    Biofouling; 2021 Mar; 37(3):341-351. PubMed ID: 33947279
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antifungal activity of peptide MSI-1 against Cryptococcus neoformans infection in vitro and in murine cryptococcal meningoencephalitis.
    Ma L; Wei S; Ye X; Xu P; Chen H; Liu Z; Zhou C
    Peptides; 2020 Aug; 130():170334. PubMed ID: 32504765
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anti-biofilm activity of the metabolites of Streptomyces chrestomyceticus strain ADP4 against Candida albicans.
    Srivastava V; Dubey AK
    J Biosci Bioeng; 2016 Oct; 122(4):434-40. PubMed ID: 27117484
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Antifungal Action Mode of
    Staniszewska M; Kuryk Ł; Gryciuk A; Kawalec J; Rogalska M; Baran J; Kowalkowska A
    Molecules; 2021 Sep; 26(18):. PubMed ID: 34576932
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Susceptibility of Cryptococcus neoformans biofilms to antifungal agents in vitro.
    Martinez LR; Casadevall A
    Antimicrob Agents Chemother; 2006 Mar; 50(3):1021-33. PubMed ID: 16495265
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bigger Data Approach to Analysis of Essential Oils and Their Antifungal Activity against
    Powers CN; Satyal P; Mayo JA; McFeeters H; McFeeters RL
    Molecules; 2019 Aug; 24(16):. PubMed ID: 31394798
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Unexplored antifungal activity of linear battacin lipopeptides against planktonic and mature biofilms of C. albicans.
    De Zoysa GH; Glossop HD; Sarojini V
    Eur J Med Chem; 2018 Feb; 146():344-353. PubMed ID: 29407961
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.